Several molecules and cellular pathways have been implicated in nociceptive signaling, but their precise molecular mechanisms have not been clearly defined. Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine͞threonine kinase implicated in the development and disease of the mammalian nervous system. The precise role of this kinase in sensory pathways has not been well characterized. Here we report a molecular role for Cdk5 in nociception. We identified the expression of Cdk5 and its activator p35 in nociceptive neurons, which is modulated during a peripheral inflammatory response. Increased calpain activity in sensory neurons after inflammation resulted in the cleavage of p35 to p25, which forms a more stable complex with Cdk5 and, consequently, leads to elevation of Cdk5 activity. p35 knockout mice (p35 ؊/؊ ), which exhibit significantly decreased Cdk5 activity, showed delayed responses to painful thermal stimulation compared with WT controls. In contrast, mice overexpressing p35, which exhibit elevated levels of Cdk5 activity, were more sensitive to painful thermal stimuli than were controls. In conclusion, our data demonstrate a role for Cdk5͞p35 activity in primary afferent nociceptive signaling, suggesting that Cdk5͞p35 may be a target for the development of analgesic drugs.
P
ain is a combination of sensory (discriminative) and affective (emotional) components. The sensory component of pain is defined as nociception and is required for survival and the maintenance of the integrity of the organism. However, sustained or chronic pain, particularly in humans, can result in secondary symptoms such as anxiety, depression, and a marked decrease in the quality of life (1, 2) . Specific cell types and several molecules have been identified that detect and regulate nociceptive activity. Additionally, the parallel pathways that distribute nociceptive information to limbic or sensory areas of the forebrain have been elucidated, but the underlying molecular mechanisms remain unclear. So far, studies using genetically modified mice, antisense knockdowns in cells, gene expression assays (including DNA microarray-based expression profiling), and linkage mapping have identified several genes the expression levels of which are directly or indirectly affected during pain sensation and͞or that are involved in modulating pain (3) . As a result, the number of proteins encoded by these genes continues to expand, and further investigation of their participation in pain pathways is required.
Cyclin-dependent kinase 5 (Cdk5), a unique member of the cyclin-dependent kinases (which belong to a family of small proline-directed serine͞threonine kinases), is mainly active in postmitotic neurons because of the selective neuronal expression of its activators, p35 and p39 (4, 5) . Transcriptional and translational regulation of p35 and p39 plays a key role in the maintenance of normal Cdk5 activity. We and others have previously reported critical roles for Cdk5 and its activators in the development of the mammalian nervous system (6) (7) (8) (9) . Emerging evidence of Cdk5's involvement in several neuronal functions, such as neuronal migration, neurotransmitter release, neuronal plasticity, memory, learning, addiction, and apoptosis, has established Cdk5 as a potential master regulator of many vital neuronal functions (10) . Although Cdk5 regulates these critical functions, its deregulation via the calpain-dependent cleavage of its activator p35 to p25 has been implicated in neurodegenerative disorders such as Alzheimer's and Parkinson's diseases (11, 12) . Patients affected by these diseases not only exhibit impaired neuronal functions but also endure chronic pain (13, 14) .
Until now there has been no direct evidence indicating the involvement of Cdk5 in nociceptive processes. However, several known substrates and proteins that interact with Cdk5 have been linked to nociceptive pathways, suggesting that Cdk5 may be involved directly or indirectly in nociception. In pain signaling, much attention has been focused on the signal transduction mechanisms in primary afferent neurons responsible for the modulation of nociceptive transmission. Activation of mitogenactivated protein kinase (MAPK) in nociceptive neurons leads to pain hypersensitivity through transcription-dependent and -independent means (15, 16) , and Cdk5͞p35 is involved in altering the MAPK pathway (17) . Calcium calmodulin kinase II (CAMKII) plays a key role in nociceptive transmission (18) (19) (20) , and Cdk5 interacts with CAMKII signal transduction pathways (21) . Cdk5 is also a downstream target of ⌬FosB (22), a c-fos family member that is upregulated during pain sensation (23, 24) . The NMDA receptor and P͞Q type voltage-dependent calcium channel (VDCC) are also phosphorylated by Cdk5 (25, 26) and control calcium influx during sensation of pain (27, 28) . Additionally, when roscovitine, a Cdk5 inhibitor, was administered intrathecally to rats, it attenuated formalin-induced nociceptive responses (29) . These cumulative findings implicate involvement of Cdk5 in nociception.
In the present study, we identified the expression and specific activity of Cdk5͞p35 in dorsal root ganglia (DRG), trigeminal ganglia (TG), and spinal cord (SC) and characterized alterations in Cdk5͞p35 protein levels and Cdk5 activity in response to peripheral inflammation. Moreover, we showed that p35 knockout mice (p35 Ϫ/Ϫ mice) and transgenic mice overexpressing p35 (Tgp35 mice) exhibit differentially altered responses to basal thermal stimulation. These findings suggest that Cdk5͞p35 activity is important for primary afferent nociceptive signaling.
Results

Cdk5 and p35 Are Expressed in Pain-Sensing Fibers.
To analyze Cdk5 and p35 mRNA expression in the peripheral nervous system, we performed in situ hybridization on DRG, TG, and SC isolated from mice (Fig. 1A) . The expression patterns of Cdk5 and p35 are similar in these tissues. Cdk5 and p35 were strongly expressed in DRG compared with SC. To identify the specific subset of neurons in DRG that express Cdk5 and͞or p35, immunocytochemical localization was performed on 4-day-old DRG neurons in culture. Immunoreactivity for Cdk5, p35, and TRPV1 was detected with specific primary antibodies against these proteins and visualized by fluorescence-labeled respective secondary antibodies. Confocal analyses of these neurons indicated that Cdk5 and p35 were consistently colocalized in most of the DRG neurons. Cdk5 also colocalized with TRPV1 (a specific marker for nociceptive C fibers), indicating that Cdk5 and p35 are present in the same set of primary afferent neurons (Fig. 1B) .
Cdk5 Activity Is Present in DRG, TG, and SC. To determine Cdk5 activity in DRG and TG neurons, Cdk5 was immunoprecipitated from these tissues with an anti-Cdk5 antibody, and kinase activity was measured with histone H1 as a substrate. The autoradiogram obtained from the kinase assay indicated substantial Cdk5 activity in DRG and TG neurons of both rats and mice ( Fig. 2A) , whereas significantly lower levels of Cdk5 activity were observed in the DRG and TG of p35 Ϫ/Ϫ mice (Fig. 2B) . Because histone H1 can also be a substrate for extracellular signal-regulated protein kinases 1 and 2 (ERK1͞2), we analyzed the specificity of Cdk5 activity by using the Cdk5-specific inhibitor roscovitine and the ras͞mitogen-activated protein kinases 1 and 2 (MEK1͞2) inhibitor PD-98059 in identical kinase assays (Fig. 2C) . We observed an 80% reduction in phosphorylated histone H1 levels after adding roscovitine compared with controls. The addition of PD-98059 resulted in only a 10% inhibition, suggesting that most of the kinase activity present in Cdk5 immunoprecipitates was derived from Cdk5, not ERK1͞2.
Inflammation Modulates Cdk5͞p35 Protein Levels. To identify the levels of Cdk5͞p35 after induction of inflammation, we injected carrageenan s.c. into the left plantar hind paw of rats. Animals were killed at different time points after injection, and tissue lysates were prepared from lumbar SC dorsal horn, from L4, L5, and L6 DRG, and from right side DRG, which served as control. Western blot analysis revealed that, in carrageenan-injected paws, Cdk5 protein levels increased in a time-dependent manner and were significantly higher as early as 3 hr after inflammation and remained significantly increased until 24 hr after inflammation, compared with their respective controls in both DRG and SC (Fig. 3 A and B) . Western blot analysis of p35, when using the C terminus-specific antibody C19, showed the formation of p25 in both DRG and SC tissues after inflammation ( Fig. 3 C and  D) . p25 was detected as early as 3 hr after inflammation in DRG and SC. We did not observe a reduction in p35 protein levels because of p25 formation, suggesting that, apparently, p35 protein levels were increased because of induced inflammation.
Fig. 1. Cdk5͞p35 expression in pain-sensing fibers. (A)
In situ hybridization (ISH) was performed on TG, DRG, SC, and brain sections by using specific probes for Cdk5 (Left) and p35 (Right). Antisense probe for Cdk5 (a-c) and p35 (g-i) detected specific mRNA expression, whereas sense probe for Cdk5 (d-f ) and p35 (j-l) served as control for respective tissues. (a, d, g, and j) The region above the line contains neuron (N) cell bodies and that below the line shows axon bundles wrapped by Schwann (S) cells. ISH signal was seen over neurons in several regions of the TG and DRG but not over axon tracts wrapped by Schwann cells. Some neurons showed a higher level of expression of Cdk5 than others, suggesting the presence of more than one neuron type in the ganglion. (b) The neurons outlined by the box showed a lower level of ISH signal than did the neurons indicated by the arrowheads in DRG. Expression pattern of Cdk5 and p35 overlaps in these tissues. (c and i) Cdk5 and p35 were expressed strongly in neurons of the DRG but were expressed at a much lower level in neurons of the SC (arrowheads). (B) Immunocytochemical analysis of Cdk5, p35, and TRPV1 in cultured DRG neurons. Cdk5 (green) and p35 (red) colocalize in these neurons (a-d), and Cdk5 (green) colocalizes with the C fiber-specific marker TRPV1 (red) (e-h). DAPI (blue) was used for nuclear staining. (Scale bar, 20 m.)
Fig. 2.
Cdk5 activity is present in DRG and TG. (A and B) Cdk5 was immunoprecipitated from lysates of rat and mouse SC, TG, and DRG and subjected to a histone H1 kinase assay. Cdk5 activity was present in SC, TG, and DRG from WT mice and rats (A) but not in TG or DRG of p35 Ϫ/Ϫ mice (p35 KO mice) (B). Autoradiographs (Upper) and the corresponding Coomassie blue-stained gels of histone H1 (Lower) are shown. (C) Cdk5 was immunoprecipitated from lysates of rat DRG and subjected to a kinase assay by using the specific inhibitor for Cdk5, roscovitine, and an inhibitor for MEK1͞2, PD-98059 (PD). Reduced phosphorylation of histone H1 in roscovitine-treated samples confirmed the specificity of Cdk5 activity in DRG. The autoradiograph (Upper) and the corresponding Coomassie blue-stained gel of histone H1 (Lower) are shown.
Inflammation Results in Increased Calpain Activity. Inflammation is known to increase calcium influx in sensory neurons. We tested the activity of the calcium-dependent protease calpain in DRG neurons and SC after induction of inflammation. A significant increase in calpain activity was observed as early as 30 min, which increased to Ͼ2-fold at 24 hr both in DRG and SC (Fig. 3 E and F) .
Inflammation Increases Cdk5 Activity. We analyzed the effects of inflammation on Cdk5 activity in DRG (Fig. 4A) and SC (Fig.  4B) . In vitro kinase assays using histone H1 as a substrate revealed a significant increase in Cdk5 activity as early as 3 hr after inflammation, and activity remained higher than that in their respective controls up to 24 hr after inflammation. Because histone H1 can be phosphorylated by several other kinases, we also confirmed the specificity of Cdk5 activity in these samples by using NF-H peptide, which is a Cdk5-specific substrate (30) . Increased Cdk5 activity was also detected with specific substrate (Fig. 4E) . The elevated Cdk5 activity was consistent with the formation of p25 protein. This elevated Cdk5 activity could be caused by increased levels of p35 and͞or p25, because Tgp35 mice or transgenic mice overexpressing p25 also have increased Cdk5 activity (8, 31) .
Altered Nociceptive Response in p35 ؊/؊ and Tgp35 Mice to Basal
Thermal Stimuli. Because Cdk5 activity was increased as a result of inflammation (Fig. 4) , we analyzed nociceptive behavior in p35 Ϫ/Ϫ mice, which have significantly reduced Cdk5 activity caused by the lack of p35 (32), and Tgp35 mice, which exhibit Cdk5 hyperactivity because of p35 overexpression (8) . We tested the basal thermal nociceptive responses in these mice by using the Hargreaves test (HT) (Fig. 5A ) and tail withdrawal test (TW) (Fig. 5B) . In both tests, p35
Ϫ/Ϫ mice showed withdrawal latencies of longer duration, whereas Tgp35 mice showed hypersensitivity to noxious thermal stimuli. At least a 2-fold increase in response time was observed in p35 Ϫ/Ϫ mice (HT WT, 3.33 Ϯ 0.12, and p35 Ϫ/Ϫ , 6.51 Ϯ 0.19; TW WT, 5.72 Ϯ 0.16, and p35 Ϫ/Ϫ , 12.56 Ϯ 0.34). In contrast, Tgp35 mice showed an inverted response, and (E and F) DRG (E) and SC (F) from carrageenantreated rats were collected 30 min and 1, 3, 6, 12, and 24 hr after treatment and subjected to a calpain enzyme activity assay by using Ac-LLY-AFC as a substrate. Relative fluorescence units (RFU) were compared to check the fold difference in enzyme activity. Calpain enzyme activity increased as a result of inflammation. All data are presented as the mean Ϯ SEM (n ϭ 3). * , P Ͻ 0.05 and ** , P Ͻ 0.01 by using one-way ANOVA. The fold difference is shown. * , P Ͻ 0.05 and ** , P Ͻ 0.01 by using one-way ANOVA. (E) The specificity of Cdk5 activity was confirmed by using the NF-H peptide as a substrate in kinase assays from control DRG and inflammation-induced DRG. All data are presented as the mean Ϯ SEM (n ϭ 3). ** , P Ͻ 0.01 by using Student's t test.
mice were more sensitive to thermal stimulation (at least Ϸ1.75-fold more rapid withdrawal latency then their respective controls) in both experiments (HT WT, 3.56 Ϯ 0.12, and Tgp35, 2.20 Ϯ 0.21; TW WT, 5.54 Ϯ 0.13, and Tgp35, 3.13 Ϯ 0.28).
Discussion
Although expression and activity of Cdk5 in the peripheral nervous system have been reported (33, 34) , the precise molecular functions of this kinase in DRG and TG neurons have not been fully characterized. Our studies demonstrate that Cdk5 and p35 are expressed in DRG and TG and that Cdk5 activity was increased during a peripheral inflammatory response. Genetically altered mice for the p35 gene (p35 Ϫ/Ϫ and Tgp35 mice) showed altered phenotypes in response to basal noxious thermal stimulation. Immunocytochemical localization and Western blot analysis showed the presence of Cdk5͞p35 in DRG and TG, specifically in neurons with an expression pattern consistent with C fiber nociceptors. In vitro kinase assays revealed the activity of Cdk5 in these neurons, which was confirmed by treatment with roscovitine and PD-98059. Additionally, Western blot analysis showed increased levels of Cdk5 as a result of peripheral inf lammation. Extracellular signal-regulated protein kinase (ERK) is a mitogen-activated protein kinase (MAPK) that mediates intracellular signal transduction in response to a variety of stimuli. It has been reported that phosphorylation of ERK caused by ras͞mitogen-activated protein kinase (MEK) activation occurs in the DRG and dorsal horn neurons in response to noxious stimulation of peripheral tissue (16) . We also observed higher phosphorylation of MEK1͞2 at both serine 217 and serine 221 (data not shown). We postulate that Cdk5͞p35 levels increased because of phospho-ERK1͞2 activation, which regulates transcription factor c-fos and early growth response 1 (EGR1), responsible for Cdk5 and p35 transcription, respectively (22, 35) . These increased levels of Cdk5, p35, and p25 contribute to increased Cdk5 activity.
It has been reported that activation of calpain is involved in the sensitization of nociceptive neurons (36) . Our findings are consistent with this observation. We found increased calpain activity in response to peripheral inflammation, which was correlated with the enhanced formation of p25, produced by calcium-dependent, calpain-mediated proteolytic cleavage of p35 (37, 38) . In the present study, we did not observe decreased p35 levels after the appearance of p25, possibly because p35 levels increased as a result of the inflammatory response.
p35
Ϫ/Ϫ mice, which exhibit significantly decreased Cdk5 activity, showed delayed responses to painful thermal stimulation. In contrast, Tgp35 mice, which exhibit elevated levels of Cdk5 activity, were hypersensitive to painful thermal stimuli, suggesting that Cdk5͞p35-dependent factors are involved in acute nociceptive signaling.
Our data indicate an important role for Cdk5͞p35 activity in primary afferent nociceptive signaling. Molecular consequences of modulated Cdk5 activity caused by peripheral inflammation still need to be elucidated. Although genetically modified mice for the p35 gene showed altered pain phenotypes, conditional deletion of Cdk5 in pain-sensing fibers will provide more detailed insight into its role in these cells.
Materials and Methods Experimental Animals. Six-to 8-week-old male p35
Ϫ/Ϫ or Tgp35 mice (8, 32) were used for these studies. Age-matched male C57BL6͞129SVJ and FVBN WT mice (The Jackson Laboratory) served as controls for p35 Ϫ/Ϫ and Tgp35 mice, respectively. Eight-to 10-week-old male Sprague-Dawley rats (HarlanSprague-Dawley) were used for peripheral inflammation studies. All animals were housed in standard cages and maintained in climate-and light-controlled rooms (22 Ϯ 0.5°C, 12͞12-hr dark͞light cycle) with free access to food and water. Studies were performed in compliance with National Institutes of Health guidelines on the care and use of laboratory and experimental animals. All experimental procedures were approved by the Animal Care and Use Committee of the National Institute of Dental and Craniofacial Research. DRG Cultures. Pregnant female rats or mice were killed, and embryos were removed from the uterus at embryonic day 15 (39) . Cells were dissociated with 0.125% trypsin͞EDTA in Ca 2ϩ ͞Mg 2ϩ -free Hanks' balanced salt solution (HBSS) for 30 min at 35°C, and an aliquot was stained with trypan blue to count the viable cells. For plating, dissociated cells were suspended into MEM containing 5% horse serum and 50 ng͞ml nerve growth factor (NGF). Cells were seeded on 25-mm glass coverslips or on multiwell plates. Surfaces were coated with poly-D-lysine and laminin. DRG cultures were maintained in DMEM containing 20 mM Hepes, 7.5% FBS, 7.5% horse serum, and 5 mg͞ml uridine supplemented with 2 mg͞ml 5-fluoro-2-deoxyuridine to inhibit cell division and 50 ng͞ml NGF to promote neuronal survival and differentiation. Cultures were incubated in this medium for 4-5 days, at which point well differentiated neurons and nondividing cells dominated the population. Primary DRG cultures at this stage were analyzed by confocal microscopy.
Antibodies. Anti-p35 (C19) and Cdk5 (J3 and C8) antibodies (Santa Cruz Biotechnology) were used at a 1:200 dilution for Western blot analysis and a 1:50 dilution for immunohistochemical localization, and 5 g was used for immunoprecipitation. For TRPV1 immunocytochemical localization, rabbit polyclonal TRPV1 (1:10,000) was purchased from Affinity Bioreagents (Golden, CO), and anti-actin antibody (1:2,000) was purchased from Sigma-Aldrich. Secondary horseradish peroxidaseconjugated antibodies (1:2,000) were obtained from Amersham Pharmacia Biosciences. Secondary fluorescence-conjugated Alexa-Fluor 633, Texas red antibodies, and ProLong Gold antifade reagent with DAPI (all from Molecular Probes) were used at a 1:400 dilution.
In Situ Hybridization. Tissues were fixed overnight in 4% paraformaldehyde containing PBS, then dehydrated and infiltrated with paraffin. Serial sections, 5-8 m, were mounted on gelatincoated slides. Two sections for each sample were mounted on one slide, deparaffinized, and rehydrated. The sections were digested with proteinase K, treated with triethanolamine͞acetic 5 . Cdk5 activity is important for the basal thermal response in mice. WT, p35 Ϫ/Ϫ , and Tgp35 mice were subjected to the HT (A) and TW (B). C57BL6͞ 129SVJ and FVBN WT mice served as controls for p35 Ϫ/Ϫ and Tgp35 mice, respectively. In all four groups, a total of 10 mice was used for each test. Data are presented as the mean Ϯ SEM (n ϭ 8 -10). ** , P Ͻ 0.01 by using Student's t test. p35 Ϫ/Ϫ mice exhibited a delayed basal thermal response compared with WT controls. Tgp35 mice showed increased sensitivity toward basal thermal stimuli.
anhydride, washed, and dehydrated. The cRNA transcripts were synthesized in vitro according to the manufacturer's conditions (Ambion, Austin, TX) and labeled with 35 S-UTP [Ͼ1,000 Ci͞ mmol (1 Ci ϭ 37 GBq); Amersham Pharmacia Biosciences]. Sections were hybridized overnight at 55°C in 50% deionized formamide, 0.3 M NaCl, 20 mM Tris⅐HCl (pH 7.4), 5 mM EDTA, 10 mM NaPO 4 , 10% dextran sulfate, 1ϫ Denhardt's solution, 50 g͞ml total yeast RNA, and 50,000-80,000 cpm per l 35 Slabeled cRNA probe. The tissue was subjected to stringent washing at 65°C in 50% formamide, 2ϫ SSC, and 10 mM DTT and washed in PBS before treatment with 20 g͞ml RNase A at 37°C for 30 min. After washes in 2ϫ SSC and 0.1ϫ SSC for 10 min at 37°C, the slides were dehydrated, dipped in Kodak NTB-2 nuclear track emulsion, and exposed for 21 days in light-tight boxes with desiccant at 4°C. Photographic development was carried out in Kodak D-19 film developer. Slides were counterstained lightly with hematoxylin and eosin and analyzed by using both light-and dark-field optics. The antisense probe detects the mRNA, and the sense control probe shows the background level of silver grains.
Immunocytochemical Localization. DRG neurons cultured on glass coverslips were fixed with ice-cold methanol for 10 min, washed three times with PBS, and blocked with blocking solution [5% (vol͞vol) normal goat serum͞PBS] for 30 min. After blocking, cells were incubated overnight at 4°C with primary antibodies and diluted in blocking solution. The next day, cells were washed with PBS and incubated with blocking solution for 30 min at room temperature. Primary antibodies were then detected by using goat anti-mouse or goat anti-rabbit IgGs coupled to Alexa-Fluor 633 or Texas red diluted in blocking solution and incubated for 1 hr at room temperature. Nuclei were counterstained by using ProLong Gold antifade reagent with DAPI (Molecular Probes). Coverslips were mounted in Gel͞Mount (Biomeda, Foster City, CA). Fluorescence images were acquired by using a confocal microscope (63ϫ oil-immersion objective on a Zeiss LSM 510). Images were combined by using Zeiss LSM 510 imaging software and managed in ADOBE PHOTOSHOP (Adobe Systems, San Jose, CA).
Induction of Inflammation.
To examine Cdk5 and p35 protein levels and kinase activity during persistent nociceptive activation, we used a well established peripheral inflammation model of pain in rodents. Injection of carrageenan induces inflammation, hypersensitivity, and some apparent spontaneous pain with a peak effect at 3-5 hr postinjection (40) (41) (42) . Carrageenan (4% in PBS, Sigma) was suspended by sonication in saline and injected s.c. in a volume of 100 l into the left plantar hind paw by using an insulin syringe with a 28-gauge needle. Contralateral right hind paws served as the controls. Animals were killed at 30 min and 1, 3, 6, 12, and 24 hr after injection. Dorsal horns from the lumbar SC region and L4, L5, and L6 DRG were collected and immediately frozen to prepare protein lysates.
Immunoblot Analysis. Tissue homogenates were prepared in a lysis buffer consisting of 50 mM Tris⅐HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 1 mM DTT, 1 mM phenylmethylsulfonyl fluoride, 1 g͞ml aprotinin, 1 g͞ml leupeptin, and 1:100 diluted phosphatase inhibitor mixtures I and II (Sigma). After a 30-min incubation on ice, insoluble material was removed by centrifugation at 4°C at 10,000 ϫ g, and the protein concentration of the supernatant was determined by using the BCA Protein Assay (Pierce). Proteins were denatured by boiling with NuPAGE LDS sample preparation buffer and sample reducing agent (Invitrogen) for 10 min. Equal amounts (100 g) of proteins were electrophoresed in 4-12% [bis(2-hydroxyethyl)amino]tris(hydroxyl)methane (Bistris) polyacrylamide gels (NuPAGE, Invitrogen) and transferred to 0.45-m pore-size nitrocellulose membranes (Invitrogen). The membranes were blocked for 2 hr in Tris-buffered saline containing 10% blocker nonfat dry milk (Bio-Rad) and 0.05% Tween 20 and incubated with primary antibodies diluted in blocking solution overnight at 4°C. Incubation with horseradish peroxidaseconjugated anti-mouse or anti-rabbit IgG was performed at room temperature for 1 hr. Immunoreactivity was detected by enhanced chemiLuminescence (Pierce). Membranes were stripped for 30 min at 50°C in 63 mM Tris⅐HCl, pH 6.8, containing 100 mM 2-mercaptoethanol and 2% SDS and reprobed with anti-actin antibody to normalize for protein loading. Optical densities of the bands were quantified by using an image analysis system with NIH IMAGE software, version 1.62 (http:͞͞rsb.info.nih.gov͞nih-image).
Cdk5 Activity Assay. Tissue or cell lysates containing 500 g of protein were diluted in lysis buffer to a volume of 500 l and precleared with 50 l of Protein A-Agarose beads (50% slurry in lysis buffer; Santa Cruz Biotechnology) at 4°C for 2 hr. Cdk5 was immunoprecipitated with 5 g of anti-Cdk5 IgG from precleared lysates by overnight incubation at 4°C, followed by a 3-hr incubation at 4°C with 25 l of Protein A-Agarose beads. Immunoprecipitates were washed twice with lysis buffer and twice with kinase buffer [20 mM Tris⅐HCl (pH 7.4), 10 mM MgCl2, 1 mM EDTA, 10 M NaF, and 1 M Na 2 VO 3 ] and resuspended in 30 l of water. Ten microliters of kinase assay mixture [100 mM Tris⅐HCl (pH 7.4), 50 mM MgCl 2 , 5 mM EDTA, 50 M NaF, 5 M Na 2 VO 3 , and 5 mM DTT] and 10 g of histone H1 (Sigma) or 0.2 M NF-H peptide (VKSPAKEKAKSPVK) were added to 30 l of the immunoprecipitates. Kinase assays were carried out at 30°C for 60 min by addition of 5 Ci [␥ 32 P]ATP (0.5 mM). To check the specificity of Cdk5 activity, 10 M of either roscovitine (Biomol, Plymouth Meeting, PA) or PD-98059 (Calbiochem) was added to inhibit Cdk5 or MEK activity, respectively. The reaction was stopped by adding 5ϫ SDS sample buffer and boiling for 5 min in a histone H1 kinase assay and by adding a similar volume of 10% trichloroacetic acid in a peptide assay. To detect histone H1 phosphorylation, 20-l aliquots were electrophoresed on a 10% polyacrylamide gel, which was stained with Coomassie blue, destained, dried, and exposed overnight to a phosphor screen (Amersham Pharmacia Biosciences). The phosphor screen was scanned on a STORM PhosphorImager (Molecular Dynamics), and the bands were quantified with IMAGEQUANT software (Molecular Dynamics). To assay peptide phosphorylation, 20-l aliquots were transferred onto P81 phosphocellulose squares (spotted in duplicates), air-dried, and washed five times for 15 min each in 75 mM phosphoric acid and once in 95% ethanol. Air-dried strips were transferred to vials containing Biosafe II scintillation fluid (Research Products International) for counting in a scintillation counter (Beckman, model SL 3801).
Calpain Activity Assay. Calpain activity in protein lysates was analyzed by using a commercially available calpain activity assay kit (Biovision, Mountain View, CA) according to the manufacturer's instructions. Calpain activity was calculated as relative fluorescence units.
HT. Radiant heat from a focused projector lamp was used to measure basal sensitivity to noxious thermal stimulation (43) . Each mouse was placed in an individual glass chamber (12.5 ϫ 12.5 ϫ 12.5 cm) with transparent outer walls to allow for experimental observation and a 3͞16-inch-thick (1 in ϭ 2.54 cm) glass floor. Mice were acclimated for at least 2 hr before testing. The stimulus was a high-intensity beam (setting of 3, Ͼ 45 W) from a projector lamp bulb located 6 cm below the glass floor that was aimed at the plantar surface of the midhind paw of an inactive mouse. Paw-withdrawal latency was measured to the nearest 0.1 sec. Response latencies were robust against changes associated with repeated testing; thus, we tested each mouse five times, over a 4-hr testing period.
TW. This test was a modified version (44) of the classic tail-flick test (45) . Mice were lightly restrained in a cloth into which they entered voluntarily. The protruding distal half of the tail was dipped into a bath of circulating water thermostatically controlled at 49°C. Latency of response to the heat stimulus by vigorous flexion of the tail was measured to the nearest 0.1 sec. Three separate withdrawal latency determinations (separated by Ն20 sec) were averaged. Because latencies in this test are known to be affected by tail skin temperature (46) , careful attention was paid to ensure that the ambient temperature was maintained at 22-23°C.
Statistical Analysis. All experiments were performed a minimum of three times. Statistical evaluation was done with GRAPHPAD PRISM software, version 4.0 (GraphPad, San Diego). Significant differences between experiments were assessed by univariate ANOVA (more than two groups) or unpaired Student's t test (two groups). ANOVA was followed by t tests using a Bonferroni ␣-correction for multiple comparisons, where ␣ was set at 0.05.
